• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一个家族性假性甲状旁腺功能减退症 1A 患者中的新型 GNAS 突变。

Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A.

机构信息

Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy.

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

出版信息

BMC Pediatr. 2024 Apr 25;24(1):271. doi: 10.1186/s12887-024-04761-8.

DOI:10.1186/s12887-024-04761-8
PMID:38664677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11044326/
Abstract

BACKGROUND

Pseudohypoparathyroidism (PHP) is caused by loss-of-function mutations at the GNAS gene (as in the PHP type 1A; PHP1A), de novo or inherited at heterozygous state, or by epigenetic alterations at the GNAS locus (as in the PHP1B). The condition of PHP refers to a heterogeneous group of disorders that share common clinical and biological features of PTH resistance. Manifestations related to resistance to other hormones are also reported in many patients with PHP, in association with the phenotypic picture of Albright hereditary osteodystrophy characterized by short stature, round facies, subcutaneous ossifications, brachydactyly, mental retardation and, in some subtypes, obesity. The purpose of our study is to report a new mutation in the GNAS gene and to describe the significant phenotypic variability of three sisters with PHP1A bearing the same mutation.

CASE PRESENTATION

We describe the cases of three sisters with PHP1A bearing the same mutation but characterized by a significantly different phenotypic picture at onset and during follow-up in terms of clinical features, auxological pattern and biochemical changes. Clinical exome sequencing revealed a never before described heterozygote mutation in the GNAS gene (NM_000516.5 c.118_139 + 51del) of autosomal dominant maternal transmission in the three siblings, confirming the diagnosis of PHP1A.

CONCLUSIONS

This study reported on a novel mutation of GNAS gene and highlighted the clinical heterogeneity of PHP1A characterized by wide genotype-phenotype variability. The appropriate diagnosis has crucial implications for patient care and long-term multidisciplinary follow-up.

摘要

背景

假性甲状旁腺功能减退症(PHP)是由 GNAS 基因(如 PHP1A 型)功能丧失突变引起的,这些突变以杂合状态存在或为新生突变,或由 GNAS 基因座的表观遗传改变引起(如 PHP1B 型)。PHP 是指一组异质性疾病,它们具有甲状旁腺素抵抗的共同临床和生物学特征。许多 PHP 患者还存在与其他激素抵抗相关的表现,这些患者与 Albright 遗传性骨营养不良的表型图片有关,其特征为身材矮小、圆脸、皮下骨化、短指(趾)畸形、智力障碍,在某些亚型中还伴有肥胖。我们研究的目的是报告 GNAS 基因的一个新突变,并描述三姐妹中 PHP1A 的显著表型变异性,她们具有相同的突变。

病例介绍

我们描述了三姐妹的病例,她们均患有 PHP1A,携带相同的突变,但在发病和随访期间表现出显著不同的表型,表现在临床特征、生长模式和生化变化方面。临床外显子组测序显示,三个姐妹均存在从未报道过的 GNAS 基因杂合突变(NM_000516.5 c.118_139 + 51del),呈常染色体显性母系遗传,这证实了 PHP1A 的诊断。

结论

本研究报告了 GNAS 基因的一个新突变,并强调了 PHP1A 的临床异质性,其特点是基因型-表型变异性广泛。正确的诊断对患者的护理和长期多学科随访具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/6dc44946e730/12887_2024_4761_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/e994b4b10c67/12887_2024_4761_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/dc255e11e313/12887_2024_4761_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/6dc44946e730/12887_2024_4761_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/e994b4b10c67/12887_2024_4761_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/dc255e11e313/12887_2024_4761_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceb0/11044326/6dc44946e730/12887_2024_4761_Fig3_HTML.jpg

相似文献

1
Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A.鉴定一个家族性假性甲状旁腺功能减退症 1A 患者中的新型 GNAS 突变。
BMC Pediatr. 2024 Apr 25;24(1):271. doi: 10.1186/s12887-024-04761-8.
2
Different AHO phenotype in a Chinese family with a novel GNAS missense variant: a case report.一个中国家族中新型 GNAS 错义变异导致的不同 AHO 表型:病例报告
Ital J Pediatr. 2022 Jul 23;48(1):123. doi: 10.1186/s13052-022-01322-6.
3
Early-Onset Obesity: Unrecognized First Evidence for GNAS Mutations and Methylation Changes.早发性肥胖:GNAS 突变和甲基化变化的首个未被识别的证据
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2670-2677. doi: 10.1210/jc.2017-00395.
4
Clinical and genetic characteristics of Pseudohypoparathyroidism in the Chinese population.中国人假性甲状旁腺功能减退症的临床和遗传特征。
Clin Endocrinol (Oxf). 2018 Feb;88(2):285-294. doi: 10.1111/cen.13516. Epub 2017 Dec 14.
5
[Paternal GNAS mutations: Which phenotypes? What genetic counseling?].[父系GNAS突变:哪些表型?如何进行遗传咨询?]
Ann Endocrinol (Paris). 2015 May;76(2):105-9. doi: 10.1016/j.ando.2015.03.010. Epub 2015 May 4.
6
Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications.假性甲状旁腺功能减退症:聚焦于脑和肾钙化
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3005-e3020. doi: 10.1210/clinem/dgab208.
7
Analysis of aberrantly spliced transcripts of a novel de novo GNAS mutant in a male with albright hereditary osteodystrophy and PHP1A.一名患有奥尔布赖特遗传性骨营养不良和PHP1A的男性中一种新的从头GNAS突变的异常剪接转录本分析。
Horm Metab Res. 2015 Jul;47(8):585-90. doi: 10.1055/s-0034-1395678. Epub 2014 Dec 12.
8
Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.18 例韩国患者中观察到的 GNAS 失活障碍的临床和分子特征。
Exp Clin Endocrinol Diabetes. 2021 Feb;129(2):118-125. doi: 10.1055/a-1001-3575. Epub 2019 Sep 23.
9
Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.GNAS 基因座的遗传和表观遗传缺陷导致不同的骨骼生长模式,但具有相似的早发性肥胖。
J Bone Miner Res. 2018 Aug;33(8):1480-1488. doi: 10.1002/jbmr.3450. Epub 2018 Jun 7.
10
A novel GNAS mutation inherited from probable maternal mosaicism causes two siblings with pseudohypoparathyroidism type 1A.一种新的 GNAS 突变可能来自母体镶嵌性,导致两兄弟患有假性甲状旁腺功能减退症 1A 型。
J Pediatr Endocrinol Metab. 2020 Sep 25;33(9):1219-1224. doi: 10.1515/jpem-2019-0476.

引用本文的文献

1
Atypical presentation of pseudohypoparathyroidism with absence of mutations in the GNAS gene: a case report.假性甲状旁腺功能减退症的非典型表现且GNAS基因无突变:一例报告
BMC Endocr Disord. 2025 Apr 18;25(1):104. doi: 10.1186/s12902-025-01933-0.
2
Pseudohypoparathyroidism: Challenges in Early Recognition and Diagnosis of a Rare Hereditary Disorder.假性甲状旁腺功能减退症:一种罕见遗传性疾病早期识别与诊断中的挑战
Cureus. 2025 Feb 19;17(2):e79321. doi: 10.7759/cureus.79321. eCollection 2025 Feb.
3
Proteome-wide assessment of differential missense variant clustering in neurodevelopmental disorders and cancer.

本文引用的文献

1
Progressive osseous heteroplasia: A case report with an unexpected trigger.进行性骨化性纤维发育不良:一例由意外诱因引发的病例报告。
Bone Rep. 2023 Feb 23;18:101665. doi: 10.1016/j.bonr.2023.101665. eCollection 2023 Jun.
2
A Novel GNAS Mutation in a Patient with Ia Pseudohypoparathyroidism (iPPSD2) Phenotype.一个伴有 Ia 假性甲状旁腺功能减退症(iPPSD2)表型的患者中存在一个新型 GNAS 突变。
Genes (Basel). 2023 Jan 26;14(2):324. doi: 10.3390/genes14020324.
3
Pseudohypoparathyroidism: application of the Italian common healthcare-pathway for a homogeneous clinical approach and a shared follow up.
神经发育障碍和癌症中错义变异差异聚类的全蛋白质组评估
Cell Genom. 2025 Apr 9;5(4):100807. doi: 10.1016/j.xgen.2025.100807. Epub 2025 Mar 11.
假性甲状旁腺功能减退症:意大利共同医疗路径的应用,实现同质化的临床诊疗方法和共同的随访。
Ital J Pediatr. 2021 Mar 4;47(1):48. doi: 10.1186/s13052-021-01000-z.
4
A novel GNAS mutation inherited from probable maternal mosaicism causes two siblings with pseudohypoparathyroidism type 1A.一种新的 GNAS 突变可能来自母体镶嵌性,导致两兄弟患有假性甲状旁腺功能减退症 1A 型。
J Pediatr Endocrinol Metab. 2020 Sep 25;33(9):1219-1224. doi: 10.1515/jpem-2019-0476.
5
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.《假性甲状旁腺功能减退症及相关疾病的诊治建议:医师和患者实用更新工具》
Horm Res Paediatr. 2020;93(3):182-196. doi: 10.1159/000508985. Epub 2020 Aug 5.
6
Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.18 例韩国患者中观察到的 GNAS 失活障碍的临床和分子特征。
Exp Clin Endocrinol Diabetes. 2021 Feb;129(2):118-125. doi: 10.1055/a-1001-3575. Epub 2019 Sep 23.
7
Pseudohypoparathyroidism.假性甲状旁腺功能减退症。
Endocrinol Metab Clin North Am. 2018 Dec;47(4):865-888. doi: 10.1016/j.ecl.2018.07.011. Epub 2018 Oct 12.
8
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.假性甲状旁腺功能减退症及相关疾病的诊断与管理:第一份国际共识声明。
Nat Rev Endocrinol. 2018 Aug;14(8):476-500. doi: 10.1038/s41574-018-0042-0.
9
The Human Phenotype Ontology in 2017.2017年的人类表型本体论。
Nucleic Acids Res. 2017 Jan 4;45(D1):D865-D876. doi: 10.1093/nar/gkw1039. Epub 2016 Nov 28.
10
Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption.GNAS基因座的遗传和表观遗传改变及假性甲状旁腺功能减退症的临床后果:意大利常见医疗保健途径的应用
Ital J Pediatr. 2016 Nov 21;42(1):101. doi: 10.1186/s13052-016-0310-3.